======= SLC6A3 ======= == Gene Information == * **Official Symbol**: SLC6A3 * **Official Name**: solute carrier family 6 member 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6531|6531]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q01959|Q01959]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC6A3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC6A3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/126455|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]. * **UniProt Summary**: Amine transporter. Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals. {ECO:0000269|PubMed:1406597, ECO:0000269|PubMed:15505207, ECO:0000269|PubMed:8302271}. |SNF| |dopamine:sodium symporter activity| |monoamine transmembrane transporter activity| |dopamine catabolic process| |catecholamine uptake| |flotillin complex| |dopamine uptake| |catechol-containing compound catabolic process| |catecholamine catabolic process| |dopamine biosynthetic process| |dopamine transport| |phenol-containing compound catabolic process| |neurotransmitter:sodium symporter activity| |dopamine binding| |adenohypophysis development| |dopaminergic synapse| |catecholamine transport| |prepulse inhibition| |catechol-containing compound biosynthetic process| |catecholamine biosynthetic process| |regulation of dopamine metabolic process| |regulation of catecholamine metabolic process| |monoamine transport| |startle response| |neurotransmitter uptake| |dopamine metabolic process| |positive regulation of multicellular organism growth| |protein phosphatase 2A binding| |response to iron ion| |phenol-containing compound biosynthetic process| |pituitary gland development| |neurotransmitter biosynthetic process| |catechol-containing compound metabolic process| |catecholamine metabolic process| |lactation| |integral component of postsynaptic membrane| |response to nicotine| |ammonium transport| |response to cocaine| |integral component of presynaptic membrane| |regulation of multicellular organism growth| |body fluid secretion| |organic hydroxy compound catabolic process| |diencephalon development| |response to anesthetic| |regulation of cellular amine metabolic process| |phenol-containing compound metabolic process| |neurotransmitter metabolic process| |response to cAMP| |protease binding| |protein N-terminus binding| |neuromuscular process| |response to alkaloid| |endocrine system development| |response to ethanol| |mammary gland development| |response to organophosphorus| |organic hydroxy compound transport| |drug catabolic process| |drug transport| |response to purine-containing compound| |positive regulation of developmental growth| |neurotransmitter transport| |response to ammonium ion| |organic hydroxy compound biosynthetic process| |ammonium ion metabolic process| |locomotory behavior| |membrane raft| |response to alcohol| |positive regulation of growth| |protein-containing complex binding| |aging| |axon| |response to xenobiotic stimulus| |response to antibiotic| |neuron projection| |regulation of developmental growth| |signaling receptor binding| |regulation of neurotransmitter levels| |negative regulation of response to external stimulus| |response to metal ion| |neuronal cell body| |forebrain development| |gland development| |aromatic compound catabolic process| |organic hydroxy compound metabolic process| |sensory perception of smell| |organic cyclic compound catabolic process| |regulation of body fluid levels| |drug metabolic process| |response to toxic substance| |response to inorganic substance| |sensory perception of chemical stimulus| |behavior| |cell surface| |regulation of growth| |import into cell| |brain development| |head development| |cation transport| |response to organic cyclic compound| |sensory perception| |central nervous system development| |response to organonitrogen compound| |response to drug| |organonitrogen compound catabolic process| |response to nitrogen compound| |regulation of response to external stimulus| |secretion| |aromatic compound biosynthetic process| |transmembrane transport| |organic cyclic compound biosynthetic process| |positive regulation of developmental process| |ion transport| |nervous system process| |organonitrogen compound biosynthetic process| |response to oxygen-containing compound| |negative regulation of response to stimulus| |positive regulation of multicellular organismal process| |organic substance catabolic process| |cellular catabolic process| |nitrogen compound transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8630 * **Expression level (log2 read counts)**: -0.59 {{:chemogenomics:nalm6 dist.png?nolink |}}